New Mesothelioma Clinical Trial Enrolls First Patient
Mesothelioma Help Now | Malignant Mesothelioma Resources
by MHN Staff
4y ago
Researchers looking for a new mesothelioma treatment are testing the combination of a cancer vaccine called galinpepimut-S and the immune checkpoint inhibitor nivolumab. With this treatment combination, doctors hope to improve survival times in patients and find an alternative to traditional treatments. As of February 2020, this mesothelioma clinical trial has already enrolled its first The post New Mesothelioma Clinical Trial Enrolls First Patient appeared first on Mesothelioma Help Now ..read more
Visit website
Dedicated Mesothelioma Doctor Working Toward More Targeted Treatment
Mesothelioma Help Now | Malignant Mesothelioma Resources
by Beth Swantek
4y ago
For a decade, Dr. Raphael Bueno has worked to sequence mesothelioma tumors in order to identify mutations. He published his work in Nature Genetics and offered his findings to mesothelioma researchers and clinicians all over the world. “We find that there are novel mutations and biological pathways that give us clues as to what target The post Dedicated Mesothelioma Doctor Working Toward More Targeted Treatment appeared first on Mesothelioma Help Now ..read more
Visit website
Study Shows That Cytoreduction With HIPEC Increases Quality of Life in Some Cases
Mesothelioma Help Now | Malignant Mesothelioma Resources
by Beth Swantek
4y ago
Researchers at Wake Forest University report that, in some cases, quality of life improves for those who undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal mesothelioma. The surgery and corresponding chemotherapy have become an accepted treatment for this type of cancer which affects the lining of the abdominal cavity (peritoneum). Peritoneal The post Study Shows That Cytoreduction With HIPEC Increases Quality of Life in Some Cases appeared first on Mesothelioma Help Now ..read more
Visit website
Mesothelioma: A Financial Hardship That Costs Families Hundreds of Thousands
Mesothelioma Help Now | Malignant Mesothelioma Resources
by Beth Swantek
4y ago
A family whose loved one receives a mesothelioma diagnosis suffers immense emotional trauma. The disease is deadly, and victims often do not live for more than a year. While much has been written about the emotional toll this condition takes on those it impacts, less has been said about the medical costs associated with the The post Mesothelioma: A Financial Hardship That Costs Families Hundreds of Thousands appeared first on Mesothelioma Help Now ..read more
Visit website
Pleural Mesothelioma Study Looks at Molecular Makeup of Tumors
Mesothelioma Help Now | Malignant Mesothelioma Resources
by MHN Staff
4y ago
International researchers are using molecular profiling to identify different types of pleural mesothelioma tumors, according to an October 2019 study. These profiles allow doctors to distinguish tumors that otherwise look very similar under a microscope, which is essential to making a correct diagnosis and administering the most effective treatments. New Findings May Help Malignant Pleural The post Pleural Mesothelioma Study Looks at Molecular Makeup of Tumors appeared first on Mesothelioma Help Now ..read more
Visit website
New Study Says Chemoimmunotherapy May Be the Future of Mesothelioma Treatment
Mesothelioma Help Now | Malignant Mesothelioma Resources
by MHN Staff
4y ago
Chemoimmunotherapy may kill cancer cells more quickly while decreasing the negative effects of chemotherapy. This could result in increased survival rates for mesothelioma patients, who often struggle to live past one or two years following their diagnosis. Chemoimmunotherapy drugs may be the “next frontier” in treating mesothelioma. What Is Chemoimmunotherapy? Chemoimmunotherapy is a promising treatment The post New Study Says Chemoimmunotherapy May Be the Future of Mesothelioma Treatment appeared first on Mesothelioma Help Now ..read more
Visit website
DIY Craze Yields Immense Danger to Homeowners Renovating Older Houses
Mesothelioma Help Now | Malignant Mesothelioma Resources
by Beth Swantek
4y ago
As a highly respected orthopedic surgeon, Geoffrey Newton certainly possessed the income to hire contractors to renovate his kitchen and bathrooms. When the family’s boiler needed to be replaced, his profession afforded him the ability to hire an HVAC specialist. Yet according to the U.K.’s Daily Mail, Newton loved to do it himself — and, The post DIY Craze Yields Immense Danger to Homeowners Renovating Older Houses appeared first on Mesothelioma Help Now ..read more
Visit website
What Mesothelioma Patients Should Know About the NovoTTF-100L Treatment System
Mesothelioma Help Now | Malignant Mesothelioma Resources
by MHN Staff
4y ago
Photo Credit: 2019 Novocure. All rights reserved. The U.S. Food & Drug Administration (FDA) recently approved a breakthrough treatment option for malignant pleural mesothelioma patients. Novocure’s NovoTTF-100L offers new hope, with clinical trials improving the prognosis of patients who used it with chemotherapy. It is the first new treatment option for the deadly disease to The post What Mesothelioma Patients Should Know About the NovoTTF-100L Treatment System appeared first on Mesothelioma Help Now ..read more
Visit website
4 Traits to Look for in Mesothelioma Cancer Centers — According to Mesothelioma Experts
Mesothelioma Help Now | Malignant Mesothelioma Resources
by MHN Staff
4y ago
At a recent International Symposium on Malignant Mesothelioma, three doctors representing some of the biggest organizations behind mesothelioma treatment discussed what patients should look for to determine a truly outstanding mesothelioma treatment center. The quality of the center you choose for your care may determine your treatment options, your prognosis, and overall, your quality of The post 4 Traits to Look for in Mesothelioma Cancer Centers — According to Mesothelioma Experts appeared first on Mesothelioma Help Now ..read more
Visit website
What Patients Should Know About the New HPN536 Mesothelioma Clinical Trials
Mesothelioma Help Now | Malignant Mesothelioma Resources
by MHN Staff
4y ago
On April 18, 2019, Harpoon Therapeutics, Inc. announced the dosing of their first patient with HPN536. HPN536 is a type of lab-created protein that causes T cells — special cells in the immune system — to target and attack mesothelioma and other cancer cells. Part 2 of the clinical trial will involve volunteers with mesothelioma. The post What Patients Should Know About the New HPN536 Mesothelioma Clinical Trials appeared first on Mesothelioma Help Now ..read more
Visit website

Follow Mesothelioma Help Now | Malignant Mesothelioma Resources on FeedSpot

Continue with Google
Continue with Apple
OR